TXNRD1 and hepatocellular carcinoma: Has-miR-125b-5p is reported to be downregulated with poor prognosis in HCC patients, and overexpression of has-miR-125b-5p inhibited the proliferation, migration, and invasion of HCC by targeting TXNRD1 (77).